Andrew Penkethman – CEO & Managing Director – Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
Copyright 2024 – Finance News Network
Source: Finance News Network
01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
Read More02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
Read More28 Aug 2020 - VRX Silica Limited (ASX:VRX) Managing Director, Bruce Maluish provides an update on the company's silica sand projects, the market for silica sand, and timelines.
Read More11 Dec 2020 - Novatti Group Limited (ASX:NOV) Managing Director Peter Cook discusses the company's strategy of partnering with Tier 1 companies, including Ripple, Google Pay and Samsung Pay.
Read More22 Nov 2022 - Radiopharmaceutical Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapies.
Read More25 Jul 2024 - Neil Herbert - Executive Chairman - Atlantic Lithium (ASX:A11) is an AIM, ASX, GSE and OTCQX-listed lithium company advancing its flagship project, the Ewoyaa Lithium Project, a significant lithium spodumene pegmatite discovery in Ghana, through to production to become the country’s first lithium-producing mine.
Read More25 Feb 2021 - Lake Resources Limited (ASX:LKE) Managing Director Steve Promnitz provides an update on the company's lithium brine projects in the lithium triangle of Argentina, and on its financials and strategy.
Read More22 Sep 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses Evergrande, the Chinese economy, implications for the Australian equity market and monetary policy.
Read More18 Sep 2024 - Venkata Gutta, CEO and Founder of MILLIBEAM, discusses the company’s mission to make millimetre-wave technology cost-effective and scalable.
Read More25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
Read More
